About this episode

The episode discusses the rise of compounded GLP-1 obesity medications, their popularity, and the safety concerns associated with them.

Sponsors

Lilly

More episodes of Endocrine News Podcast

• ENP111: Addressing the Endocrine Workforce Shortage · February 25, 2026 · 30 min
• ENP110: Hypercortisolism and T2D · January 21, 2026 · 20 min
• ENP109: Anti-Obesity Medications (CME credit available) · January 7, 2026 · 13 min
• ENP108: AI and Robotics in Surgery · December 17, 2025 · 10 min
• ENP106: Reversing Bariatric Surgery · November 12, 2025 · 12 min
• ENP105: Tirzepatide and Menopause · October 29, 2025 · 19 min

Explore listener stats, chart rankings, contacts and more on the Endocrine News Podcast podcast page.